Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody

BACKGROUND: Individuals with end-stage kidney disease (ESKD) on dialysis are vulnerable to contracting COVID-19 infection, with mortality as high as 31 % in this group. Population demographics in the UAE are dissimilar to many other countries and data on antibody responses to COVID-19 is also limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Wasim, Al Obaidli, Ali Abdul Kareem, Joseph, Princy, Smith, Edward R., Khan, Ayaz Ahmad, Anwar, Siddiq, Chandrasekar, Thangavelu, Al Madani, Ayman Kamal, Dastoor, Hormazdiar Dara, Zahid, Imran, Costales, Freddie Agbayani, Boobes, Yousef Abdul Rahim, Al Kindi, Fatima, Issa, Salah Eldin Khalil, Hassan, Mohamed H., George, Abraham, Holt, Stephen Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152185/
https://www.ncbi.nlm.nih.gov/pubmed/34039299
http://dx.doi.org/10.1186/s12882-021-02378-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152185/
https://www.ncbi.nlm.nih.gov/pubmed/34039299
http://dx.doi.org/10.1186/s12882-021-02378-y

Ejemplares similares